Cargando…
Ginsenosides: Allies of gastrointestinal tumor immunotherapy
In the past decade, immunotherapy has been the most promising treatment for gastrointestinal tumors. But the low response rate and drug resistance remain major concerns. It is therefore imperative to develop adjuvant therapies to increase the effectiveness of immunotherapy and prevent drug resistanc...
Autores principales: | Feng, Yutao, Ma, Fen, Wu, Enjiang, Cheng, Zewei, Wang, Zhengtao, Yang, Li, Zhang, Jiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659574/ https://www.ncbi.nlm.nih.gov/pubmed/36386161 http://dx.doi.org/10.3389/fphar.2022.922029 |
Ejemplares similares
-
Gut Microbiota: Novel Therapeutic Target of Ginsenosides for the Treatment of Obesity and Its Complications
por: Zhuang, Tongxi, et al.
Publicado: (2021) -
Pharmacological Properties of Ginsenoside Re
por: Gao, Xiao-Yan, et al.
Publicado: (2022) -
Emerging Significance of Ginsenosides as Potentially Reversal Agents of Chemoresistance in Cancer Therapy
por: Xu, Jin-Feng, et al.
Publicado: (2021) -
Mechanism-Based Pharmacokinetic Model for the Deglycosylation Kinetics of 20(S)-Ginsenosides Rh2
por: Ren, Hong-can, et al.
Publicado: (2022) -
The effect of ginsenosides on liver injury in preclinical studies: a systematic review and meta-analysis
por: Bian, Xing-Bo, et al.
Publicado: (2023)